COVID-19 Impact on Global Morphine Sulfat (CAS 64-31-3), Market Insights and Forecast to 2026
Morphine Sulfat (CAS 64-31-3) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Morphine Sulfat (CAS 64-31-3) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Morphine Sulfat (CAS 64-31-3) market is segmented into
The Morphine Sulfat (CAS 64-31-3) market is analysed and market size information is provided by regions (countries).
The key regions covered in the Morphine Sulfat (CAS 64-31-3) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Morphine Sulfat (CAS 64-31-3) Market Share Analysis
Morphine Sulfat (CAS 64-31-3) market competitive landscape provides details and data information by players.
The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Morphine Sulfat (CAS 64-31-3) business, the date to enter into the Morphine Sulfat (CAS 64-31-3) market, Morphine Sulfat (CAS 64-31-3) product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Morphine Sulfat (CAS 64-31-3) market is segmented into
- Pills
- Powder
- Oral Tablets
- Injection
- Capsule
- Others
The Morphine Sulfat (CAS 64-31-3) market is analysed and market size information is provided by regions (countries).
The key regions covered in the Morphine Sulfat (CAS 64-31-3) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Morphine Sulfat (CAS 64-31-3) Market Share Analysis
Morphine Sulfat (CAS 64-31-3) market competitive landscape provides details and data information by players.
The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Morphine Sulfat (CAS 64-31-3) business, the date to enter into the Morphine Sulfat (CAS 64-31-3) market, Morphine Sulfat (CAS 64-31-3) product introduction, recent developments, etc.
The major vendors covered:
- Mallinckrodt Pharmaceuticals
- Alcaliber
- Purdue Pharma
- Cepia-Sanofi
- Macfarlan Smith
- SUN PHARMA
- Qinghai Pharmaceutical
- Taj Pharmaceuticals
- Northeast Pharm
1 STUDY COVERAGE
1.1 Morphine Sulfat (CAS 64-31-3) Product Introduction
1.2 Market Segments
1.3 Key Morphine Sulfat (CAS 64-31-3) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Morphine Sulfat (CAS 64-31-3) Market Size Growth Rate by Type
1.4.2 Pills
1.4.3 Powder
1.5 Market by Application
1.5.1 Global Morphine Sulfat (CAS 64-31-3) Market Size Growth Rate by Application
1.5.2 Oral Tablets
1.5.3 Injection
1.5.4 Capsule
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Morphine Sulfat (CAS 64-31-3) Industry Impact
1.6.1 How the Covid-19 is Affecting the Morphine Sulfat (CAS 64-31-3) Industry
1.6.1.1 Morphine Sulfat (CAS 64-31-3) Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Morphine Sulfat (CAS 64-31-3) Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Morphine Sulfat (CAS 64-31-3) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Morphine Sulfat (CAS 64-31-3) Market Size Estimates and Forecasts
2.1.1 Global Morphine Sulfat (CAS 64-31-3) Revenue 2015-2026
2.1.2 Global Morphine Sulfat (CAS 64-31-3) Sales 2015-2026
2.2 Morphine Sulfat (CAS 64-31-3) Market Size by Region: 2020 Versus 2026
2.2.1 Global Morphine Sulfat (CAS 64-31-3) Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Morphine Sulfat (CAS 64-31-3) Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL MORPHINE SULFAT (CAS 64-31-3) COMPETITOR LANDSCAPE BY PLAYERS
3.1 Morphine Sulfat (CAS 64-31-3) Sales by Manufacturers
3.1.1 Morphine Sulfat (CAS 64-31-3) Sales by Manufacturers (2015-2020)
3.1.2 Morphine Sulfat (CAS 64-31-3) Sales Market Share by Manufacturers (2015-2020)
3.2 Morphine Sulfat (CAS 64-31-3) Revenue by Manufacturers
3.2.1 Morphine Sulfat (CAS 64-31-3) Revenue by Manufacturers (2015-2020)
3.2.2 Morphine Sulfat (CAS 64-31-3) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Morphine Sulfat (CAS 64-31-3) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Morphine Sulfat (CAS 64-31-3) Revenue in 2019
3.2.5 Global Morphine Sulfat (CAS 64-31-3) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Morphine Sulfat (CAS 64-31-3) Price by Manufacturers
3.4 Morphine Sulfat (CAS 64-31-3) Manufacturing Base Distribution, Product Types
3.4.1 Morphine Sulfat (CAS 64-31-3) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Morphine Sulfat (CAS 64-31-3) Product Type
3.4.3 Date of International Manufacturers Enter into Morphine Sulfat (CAS 64-31-3) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Morphine Sulfat (CAS 64-31-3) Market Size by Type (2015-2020)
4.1.1 Global Morphine Sulfat (CAS 64-31-3) Sales by Type (2015-2020)
4.1.2 Global Morphine Sulfat (CAS 64-31-3) Revenue by Type (2015-2020)
4.1.3 Morphine Sulfat (CAS 64-31-3) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Morphine Sulfat (CAS 64-31-3) Market Size Forecast by Type (2021-2026)
4.2.1 Global Morphine Sulfat (CAS 64-31-3) Sales Forecast by Type (2021-2026)
4.2.2 Global Morphine Sulfat (CAS 64-31-3) Revenue Forecast by Type (2021-2026)
4.2.3 Morphine Sulfat (CAS 64-31-3) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Morphine Sulfat (CAS 64-31-3) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Morphine Sulfat (CAS 64-31-3) Market Size by Application (2015-2020)
5.1.1 Global Morphine Sulfat (CAS 64-31-3) Sales by Application (2015-2020)
5.1.2 Global Morphine Sulfat (CAS 64-31-3) Revenue by Application (2015-2020)
5.1.3 Morphine Sulfat (CAS 64-31-3) Price by Application (2015-2020)
5.2 Morphine Sulfat (CAS 64-31-3) Market Size Forecast by Application (2021-2026)
5.2.1 Global Morphine Sulfat (CAS 64-31-3) Sales Forecast by Application (2021-2026)
5.2.2 Global Morphine Sulfat (CAS 64-31-3) Revenue Forecast by Application (2021-2026)
5.2.3 Global Morphine Sulfat (CAS 64-31-3) Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Morphine Sulfat (CAS 64-31-3) by Country
6.1.1 North America Morphine Sulfat (CAS 64-31-3) Sales by Country
6.1.2 North America Morphine Sulfat (CAS 64-31-3) Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Morphine Sulfat (CAS 64-31-3) Market Facts & Figures by Type
6.3 North America Morphine Sulfat (CAS 64-31-3) Market Facts & Figures by Application
7 EUROPE
7.1 Europe Morphine Sulfat (CAS 64-31-3) by Country
7.1.1 Europe Morphine Sulfat (CAS 64-31-3) Sales by Country
7.1.2 Europe Morphine Sulfat (CAS 64-31-3) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Morphine Sulfat (CAS 64-31-3) Market Facts & Figures by Type
7.3 Europe Morphine Sulfat (CAS 64-31-3) Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Morphine Sulfat (CAS 64-31-3) by Region
8.1.1 Asia Pacific Morphine Sulfat (CAS 64-31-3) Sales by Region
8.1.2 Asia Pacific Morphine Sulfat (CAS 64-31-3) Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Morphine Sulfat (CAS 64-31-3) Market Facts & Figures by Type
8.3 Asia Pacific Morphine Sulfat (CAS 64-31-3) Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Morphine Sulfat (CAS 64-31-3) by Country
9.1.1 Latin America Morphine Sulfat (CAS 64-31-3) Sales by Country
9.1.2 Latin America Morphine Sulfat (CAS 64-31-3) Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Morphine Sulfat (CAS 64-31-3) Market Facts & Figures by Type
9.3 Central & South America Morphine Sulfat (CAS 64-31-3) Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Morphine Sulfat (CAS 64-31-3) by Country
10.1.1 Middle East and Africa Morphine Sulfat (CAS 64-31-3) Sales by Country
10.1.2 Middle East and Africa Morphine Sulfat (CAS 64-31-3) Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Morphine Sulfat (CAS 64-31-3) Market Facts & Figures by Type
10.3 Middle East and Africa Morphine Sulfat (CAS 64-31-3) Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Mallinckrodt Pharmaceuticals
11.1.1 Mallinckrodt Pharmaceuticals Corporation Information
11.1.2 Mallinckrodt Pharmaceuticals Description, Business Overview and Total Revenue
11.1.3 Mallinckrodt Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Mallinckrodt Pharmaceuticals Morphine Sulfat (CAS 64-31-3) Products Offered
11.1.5 Mallinckrodt Pharmaceuticals Recent Development
11.2 Alcaliber
11.2.1 Alcaliber Corporation Information
11.2.2 Alcaliber Description, Business Overview and Total Revenue
11.2.3 Alcaliber Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Alcaliber Morphine Sulfat (CAS 64-31-3) Products Offered
11.2.5 Alcaliber Recent Development
11.3 Purdue Pharma
11.3.1 Purdue Pharma Corporation Information
11.3.2 Purdue Pharma Description, Business Overview and Total Revenue
11.3.3 Purdue Pharma Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Purdue Pharma Morphine Sulfat (CAS 64-31-3) Products Offered
11.3.5 Purdue Pharma Recent Development
11.4 Cepia-Sanofi
11.4.1 Cepia-Sanofi Corporation Information
11.4.2 Cepia-Sanofi Description, Business Overview and Total Revenue
11.4.3 Cepia-Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Cepia-Sanofi Morphine Sulfat (CAS 64-31-3) Products Offered
11.4.5 Cepia-Sanofi Recent Development
11.5 Macfarlan Smith
11.5.1 Macfarlan Smith Corporation Information
11.5.2 Macfarlan Smith Description, Business Overview and Total Revenue
11.5.3 Macfarlan Smith Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Macfarlan Smith Morphine Sulfat (CAS 64-31-3) Products Offered
11.5.5 Macfarlan Smith Recent Development
11.6 SUN PHARMA
11.6.1 SUN PHARMA Corporation Information
11.6.2 SUN PHARMA Description, Business Overview and Total Revenue
11.6.3 SUN PHARMA Sales, Revenue and Gross Margin (2015-2020)
11.6.4 SUN PHARMA Morphine Sulfat (CAS 64-31-3) Products Offered
11.6.5 SUN PHARMA Recent Development
11.7 Qinghai Pharmaceutical
11.7.1 Qinghai Pharmaceutical Corporation Information
11.7.2 Qinghai Pharmaceutical Description, Business Overview and Total Revenue
11.7.3 Qinghai Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Qinghai Pharmaceutical Morphine Sulfat (CAS 64-31-3) Products Offered
11.7.5 Qinghai Pharmaceutical Recent Development
11.8 Taj Pharmaceuticals
11.8.1 Taj Pharmaceuticals Corporation Information
11.8.2 Taj Pharmaceuticals Description, Business Overview and Total Revenue
11.8.3 Taj Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Taj Pharmaceuticals Morphine Sulfat (CAS 64-31-3) Products Offered
11.8.5 Taj Pharmaceuticals Recent Development
11.9 Northeast Pharm
11.9.1 Northeast Pharm Corporation Information
11.9.2 Northeast Pharm Description, Business Overview and Total Revenue
11.9.3 Northeast Pharm Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Northeast Pharm Morphine Sulfat (CAS 64-31-3) Products Offered
11.9.5 Northeast Pharm Recent Development
11.1 Mallinckrodt Pharmaceuticals
11.1.1 Mallinckrodt Pharmaceuticals Corporation Information
11.1.2 Mallinckrodt Pharmaceuticals Description, Business Overview and Total Revenue
11.1.3 Mallinckrodt Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Mallinckrodt Pharmaceuticals Morphine Sulfat (CAS 64-31-3) Products Offered
11.1.5 Mallinckrodt Pharmaceuticals Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Morphine Sulfat (CAS 64-31-3) Market Estimates and Projections by Region
12.1.1 Global Morphine Sulfat (CAS 64-31-3) Sales Forecast by Regions 2021-2026
12.1.2 Global Morphine Sulfat (CAS 64-31-3) Revenue Forecast by Regions 2021-2026
12.2 North America Morphine Sulfat (CAS 64-31-3) Market Size Forecast (2021-2026)
12.2.1 North America: Morphine Sulfat (CAS 64-31-3) Sales Forecast (2021-2026)
12.2.2 North America: Morphine Sulfat (CAS 64-31-3) Revenue Forecast (2021-2026)
12.2.3 North America: Morphine Sulfat (CAS 64-31-3) Market Size Forecast by Country (2021-2026)
12.3 Europe Morphine Sulfat (CAS 64-31-3) Market Size Forecast (2021-2026)
12.3.1 Europe: Morphine Sulfat (CAS 64-31-3) Sales Forecast (2021-2026)
12.3.2 Europe: Morphine Sulfat (CAS 64-31-3) Revenue Forecast (2021-2026)
12.3.3 Europe: Morphine Sulfat (CAS 64-31-3) Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Morphine Sulfat (CAS 64-31-3) Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Morphine Sulfat (CAS 64-31-3) Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Morphine Sulfat (CAS 64-31-3) Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Morphine Sulfat (CAS 64-31-3) Market Size Forecast by Region (2021-2026)
12.5 Latin America Morphine Sulfat (CAS 64-31-3) Market Size Forecast (2021-2026)
12.5.1 Latin America: Morphine Sulfat (CAS 64-31-3) Sales Forecast (2021-2026)
12.5.2 Latin America: Morphine Sulfat (CAS 64-31-3) Revenue Forecast (2021-2026)
12.5.3 Latin America: Morphine Sulfat (CAS 64-31-3) Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Morphine Sulfat (CAS 64-31-3) Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Morphine Sulfat (CAS 64-31-3) Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Morphine Sulfat (CAS 64-31-3) Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Morphine Sulfat (CAS 64-31-3) Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Morphine Sulfat (CAS 64-31-3) Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Morphine Sulfat (CAS 64-31-3) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Morphine Sulfat (CAS 64-31-3) Product Introduction
1.2 Market Segments
1.3 Key Morphine Sulfat (CAS 64-31-3) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Morphine Sulfat (CAS 64-31-3) Market Size Growth Rate by Type
1.4.2 Pills
1.4.3 Powder
1.5 Market by Application
1.5.1 Global Morphine Sulfat (CAS 64-31-3) Market Size Growth Rate by Application
1.5.2 Oral Tablets
1.5.3 Injection
1.5.4 Capsule
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Morphine Sulfat (CAS 64-31-3) Industry Impact
1.6.1 How the Covid-19 is Affecting the Morphine Sulfat (CAS 64-31-3) Industry
1.6.1.1 Morphine Sulfat (CAS 64-31-3) Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Morphine Sulfat (CAS 64-31-3) Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Morphine Sulfat (CAS 64-31-3) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Morphine Sulfat (CAS 64-31-3) Market Size Estimates and Forecasts
2.1.1 Global Morphine Sulfat (CAS 64-31-3) Revenue 2015-2026
2.1.2 Global Morphine Sulfat (CAS 64-31-3) Sales 2015-2026
2.2 Morphine Sulfat (CAS 64-31-3) Market Size by Region: 2020 Versus 2026
2.2.1 Global Morphine Sulfat (CAS 64-31-3) Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Morphine Sulfat (CAS 64-31-3) Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL MORPHINE SULFAT (CAS 64-31-3) COMPETITOR LANDSCAPE BY PLAYERS
3.1 Morphine Sulfat (CAS 64-31-3) Sales by Manufacturers
3.1.1 Morphine Sulfat (CAS 64-31-3) Sales by Manufacturers (2015-2020)
3.1.2 Morphine Sulfat (CAS 64-31-3) Sales Market Share by Manufacturers (2015-2020)
3.2 Morphine Sulfat (CAS 64-31-3) Revenue by Manufacturers
3.2.1 Morphine Sulfat (CAS 64-31-3) Revenue by Manufacturers (2015-2020)
3.2.2 Morphine Sulfat (CAS 64-31-3) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Morphine Sulfat (CAS 64-31-3) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Morphine Sulfat (CAS 64-31-3) Revenue in 2019
3.2.5 Global Morphine Sulfat (CAS 64-31-3) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Morphine Sulfat (CAS 64-31-3) Price by Manufacturers
3.4 Morphine Sulfat (CAS 64-31-3) Manufacturing Base Distribution, Product Types
3.4.1 Morphine Sulfat (CAS 64-31-3) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Morphine Sulfat (CAS 64-31-3) Product Type
3.4.3 Date of International Manufacturers Enter into Morphine Sulfat (CAS 64-31-3) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Morphine Sulfat (CAS 64-31-3) Market Size by Type (2015-2020)
4.1.1 Global Morphine Sulfat (CAS 64-31-3) Sales by Type (2015-2020)
4.1.2 Global Morphine Sulfat (CAS 64-31-3) Revenue by Type (2015-2020)
4.1.3 Morphine Sulfat (CAS 64-31-3) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Morphine Sulfat (CAS 64-31-3) Market Size Forecast by Type (2021-2026)
4.2.1 Global Morphine Sulfat (CAS 64-31-3) Sales Forecast by Type (2021-2026)
4.2.2 Global Morphine Sulfat (CAS 64-31-3) Revenue Forecast by Type (2021-2026)
4.2.3 Morphine Sulfat (CAS 64-31-3) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Morphine Sulfat (CAS 64-31-3) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Morphine Sulfat (CAS 64-31-3) Market Size by Application (2015-2020)
5.1.1 Global Morphine Sulfat (CAS 64-31-3) Sales by Application (2015-2020)
5.1.2 Global Morphine Sulfat (CAS 64-31-3) Revenue by Application (2015-2020)
5.1.3 Morphine Sulfat (CAS 64-31-3) Price by Application (2015-2020)
5.2 Morphine Sulfat (CAS 64-31-3) Market Size Forecast by Application (2021-2026)
5.2.1 Global Morphine Sulfat (CAS 64-31-3) Sales Forecast by Application (2021-2026)
5.2.2 Global Morphine Sulfat (CAS 64-31-3) Revenue Forecast by Application (2021-2026)
5.2.3 Global Morphine Sulfat (CAS 64-31-3) Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Morphine Sulfat (CAS 64-31-3) by Country
6.1.1 North America Morphine Sulfat (CAS 64-31-3) Sales by Country
6.1.2 North America Morphine Sulfat (CAS 64-31-3) Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Morphine Sulfat (CAS 64-31-3) Market Facts & Figures by Type
6.3 North America Morphine Sulfat (CAS 64-31-3) Market Facts & Figures by Application
7 EUROPE
7.1 Europe Morphine Sulfat (CAS 64-31-3) by Country
7.1.1 Europe Morphine Sulfat (CAS 64-31-3) Sales by Country
7.1.2 Europe Morphine Sulfat (CAS 64-31-3) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Morphine Sulfat (CAS 64-31-3) Market Facts & Figures by Type
7.3 Europe Morphine Sulfat (CAS 64-31-3) Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Morphine Sulfat (CAS 64-31-3) by Region
8.1.1 Asia Pacific Morphine Sulfat (CAS 64-31-3) Sales by Region
8.1.2 Asia Pacific Morphine Sulfat (CAS 64-31-3) Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Morphine Sulfat (CAS 64-31-3) Market Facts & Figures by Type
8.3 Asia Pacific Morphine Sulfat (CAS 64-31-3) Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Morphine Sulfat (CAS 64-31-3) by Country
9.1.1 Latin America Morphine Sulfat (CAS 64-31-3) Sales by Country
9.1.2 Latin America Morphine Sulfat (CAS 64-31-3) Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Morphine Sulfat (CAS 64-31-3) Market Facts & Figures by Type
9.3 Central & South America Morphine Sulfat (CAS 64-31-3) Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Morphine Sulfat (CAS 64-31-3) by Country
10.1.1 Middle East and Africa Morphine Sulfat (CAS 64-31-3) Sales by Country
10.1.2 Middle East and Africa Morphine Sulfat (CAS 64-31-3) Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Morphine Sulfat (CAS 64-31-3) Market Facts & Figures by Type
10.3 Middle East and Africa Morphine Sulfat (CAS 64-31-3) Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Mallinckrodt Pharmaceuticals
11.1.1 Mallinckrodt Pharmaceuticals Corporation Information
11.1.2 Mallinckrodt Pharmaceuticals Description, Business Overview and Total Revenue
11.1.3 Mallinckrodt Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Mallinckrodt Pharmaceuticals Morphine Sulfat (CAS 64-31-3) Products Offered
11.1.5 Mallinckrodt Pharmaceuticals Recent Development
11.2 Alcaliber
11.2.1 Alcaliber Corporation Information
11.2.2 Alcaliber Description, Business Overview and Total Revenue
11.2.3 Alcaliber Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Alcaliber Morphine Sulfat (CAS 64-31-3) Products Offered
11.2.5 Alcaliber Recent Development
11.3 Purdue Pharma
11.3.1 Purdue Pharma Corporation Information
11.3.2 Purdue Pharma Description, Business Overview and Total Revenue
11.3.3 Purdue Pharma Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Purdue Pharma Morphine Sulfat (CAS 64-31-3) Products Offered
11.3.5 Purdue Pharma Recent Development
11.4 Cepia-Sanofi
11.4.1 Cepia-Sanofi Corporation Information
11.4.2 Cepia-Sanofi Description, Business Overview and Total Revenue
11.4.3 Cepia-Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Cepia-Sanofi Morphine Sulfat (CAS 64-31-3) Products Offered
11.4.5 Cepia-Sanofi Recent Development
11.5 Macfarlan Smith
11.5.1 Macfarlan Smith Corporation Information
11.5.2 Macfarlan Smith Description, Business Overview and Total Revenue
11.5.3 Macfarlan Smith Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Macfarlan Smith Morphine Sulfat (CAS 64-31-3) Products Offered
11.5.5 Macfarlan Smith Recent Development
11.6 SUN PHARMA
11.6.1 SUN PHARMA Corporation Information
11.6.2 SUN PHARMA Description, Business Overview and Total Revenue
11.6.3 SUN PHARMA Sales, Revenue and Gross Margin (2015-2020)
11.6.4 SUN PHARMA Morphine Sulfat (CAS 64-31-3) Products Offered
11.6.5 SUN PHARMA Recent Development
11.7 Qinghai Pharmaceutical
11.7.1 Qinghai Pharmaceutical Corporation Information
11.7.2 Qinghai Pharmaceutical Description, Business Overview and Total Revenue
11.7.3 Qinghai Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Qinghai Pharmaceutical Morphine Sulfat (CAS 64-31-3) Products Offered
11.7.5 Qinghai Pharmaceutical Recent Development
11.8 Taj Pharmaceuticals
11.8.1 Taj Pharmaceuticals Corporation Information
11.8.2 Taj Pharmaceuticals Description, Business Overview and Total Revenue
11.8.3 Taj Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Taj Pharmaceuticals Morphine Sulfat (CAS 64-31-3) Products Offered
11.8.5 Taj Pharmaceuticals Recent Development
11.9 Northeast Pharm
11.9.1 Northeast Pharm Corporation Information
11.9.2 Northeast Pharm Description, Business Overview and Total Revenue
11.9.3 Northeast Pharm Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Northeast Pharm Morphine Sulfat (CAS 64-31-3) Products Offered
11.9.5 Northeast Pharm Recent Development
11.1 Mallinckrodt Pharmaceuticals
11.1.1 Mallinckrodt Pharmaceuticals Corporation Information
11.1.2 Mallinckrodt Pharmaceuticals Description, Business Overview and Total Revenue
11.1.3 Mallinckrodt Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Mallinckrodt Pharmaceuticals Morphine Sulfat (CAS 64-31-3) Products Offered
11.1.5 Mallinckrodt Pharmaceuticals Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Morphine Sulfat (CAS 64-31-3) Market Estimates and Projections by Region
12.1.1 Global Morphine Sulfat (CAS 64-31-3) Sales Forecast by Regions 2021-2026
12.1.2 Global Morphine Sulfat (CAS 64-31-3) Revenue Forecast by Regions 2021-2026
12.2 North America Morphine Sulfat (CAS 64-31-3) Market Size Forecast (2021-2026)
12.2.1 North America: Morphine Sulfat (CAS 64-31-3) Sales Forecast (2021-2026)
12.2.2 North America: Morphine Sulfat (CAS 64-31-3) Revenue Forecast (2021-2026)
12.2.3 North America: Morphine Sulfat (CAS 64-31-3) Market Size Forecast by Country (2021-2026)
12.3 Europe Morphine Sulfat (CAS 64-31-3) Market Size Forecast (2021-2026)
12.3.1 Europe: Morphine Sulfat (CAS 64-31-3) Sales Forecast (2021-2026)
12.3.2 Europe: Morphine Sulfat (CAS 64-31-3) Revenue Forecast (2021-2026)
12.3.3 Europe: Morphine Sulfat (CAS 64-31-3) Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Morphine Sulfat (CAS 64-31-3) Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Morphine Sulfat (CAS 64-31-3) Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Morphine Sulfat (CAS 64-31-3) Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Morphine Sulfat (CAS 64-31-3) Market Size Forecast by Region (2021-2026)
12.5 Latin America Morphine Sulfat (CAS 64-31-3) Market Size Forecast (2021-2026)
12.5.1 Latin America: Morphine Sulfat (CAS 64-31-3) Sales Forecast (2021-2026)
12.5.2 Latin America: Morphine Sulfat (CAS 64-31-3) Revenue Forecast (2021-2026)
12.5.3 Latin America: Morphine Sulfat (CAS 64-31-3) Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Morphine Sulfat (CAS 64-31-3) Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Morphine Sulfat (CAS 64-31-3) Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Morphine Sulfat (CAS 64-31-3) Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Morphine Sulfat (CAS 64-31-3) Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Morphine Sulfat (CAS 64-31-3) Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Morphine Sulfat (CAS 64-31-3) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Morphine Sulfat (CAS 64-31-3) Market Segments
Table 2. Ranking of Global Top Morphine Sulfat (CAS 64-31-3) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Morphine Sulfat (CAS 64-31-3) Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Pills
Table 5. Major Manufacturers of Powder
Table 6. COVID-19 Impact Global Market: (Four Morphine Sulfat (CAS 64-31-3) Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Morphine Sulfat (CAS 64-31-3) Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Morphine Sulfat (CAS 64-31-3) Players to Combat Covid-19 Impact
Table 11. Global Morphine Sulfat (CAS 64-31-3) Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Morphine Sulfat (CAS 64-31-3) Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global Morphine Sulfat (CAS 64-31-3) Sales by Regions 2015-2020 (K MT)
Table 14. Global Morphine Sulfat (CAS 64-31-3) Sales Market Share by Regions (2015-2020)
Table 15. Global Morphine Sulfat (CAS 64-31-3) Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Morphine Sulfat (CAS 64-31-3) Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Morphine Sulfat (CAS 64-31-3) Sales Share by Manufacturers (2015-2020)
Table 18. Global Morphine Sulfat (CAS 64-31-3) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Morphine Sulfat (CAS 64-31-3) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Morphine Sulfat (CAS 64-31-3) as of 2019)
Table 20. Morphine Sulfat (CAS 64-31-3) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Morphine Sulfat (CAS 64-31-3) Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Morphine Sulfat (CAS 64-31-3) Price (2015-2020) (USD/Unit)
Table 23. Morphine Sulfat (CAS 64-31-3) Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Morphine Sulfat (CAS 64-31-3) Product Type
Table 25. Date of International Manufacturers Enter into Morphine Sulfat (CAS 64-31-3) Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Morphine Sulfat (CAS 64-31-3) Sales by Type (2015-2020) (K MT)
Table 28. Global Morphine Sulfat (CAS 64-31-3) Sales Share by Type (2015-2020)
Table 29. Global Morphine Sulfat (CAS 64-31-3) Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Morphine Sulfat (CAS 64-31-3) Revenue Share by Type (2015-2020)
Table 31. Morphine Sulfat (CAS 64-31-3) Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Morphine Sulfat (CAS 64-31-3) Sales by Application (2015-2020) (K MT)
Table 33. Global Morphine Sulfat (CAS 64-31-3) Sales Share by Application (2015-2020)
Table 34. North America Morphine Sulfat (CAS 64-31-3) Sales by Country (2015-2020) (K MT)
Table 35. North America Morphine Sulfat (CAS 64-31-3) Sales Market Share by Country (2015-2020)
Table 36. North America Morphine Sulfat (CAS 64-31-3) Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Country (2015-2020)
Table 38. North America Morphine Sulfat (CAS 64-31-3) Sales by Type (2015-2020) (K MT)
Table 39. North America Morphine Sulfat (CAS 64-31-3) Sales Market Share by Type (2015-2020)
Table 40. North America Morphine Sulfat (CAS 64-31-3) Sales by Application (2015-2020) (K MT)
Table 41. North America Morphine Sulfat (CAS 64-31-3) Sales Market Share by Application (2015-2020)
Table 42. Europe Morphine Sulfat (CAS 64-31-3) Sales by Country (2015-2020) (K MT)
Table 43. Europe Morphine Sulfat (CAS 64-31-3) Sales Market Share by Country (2015-2020)
Table 44. Europe Morphine Sulfat (CAS 64-31-3) Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Country (2015-2020)
Table 46. Europe Morphine Sulfat (CAS 64-31-3) Sales by Type (2015-2020) (K MT)
Table 47. Europe Morphine Sulfat (CAS 64-31-3) Sales Market Share by Type (2015-2020)
Table 48. Europe Morphine Sulfat (CAS 64-31-3) Sales by Application (2015-2020) (K MT)
Table 49. Europe Morphine Sulfat (CAS 64-31-3) Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Morphine Sulfat (CAS 64-31-3) Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific Morphine Sulfat (CAS 64-31-3) Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Morphine Sulfat (CAS 64-31-3) Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Morphine Sulfat (CAS 64-31-3) Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific Morphine Sulfat (CAS 64-31-3) Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Morphine Sulfat (CAS 64-31-3) Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific Morphine Sulfat (CAS 64-31-3) Sales Market Share by Application (2015-2020)
Table 58. Latin America Morphine Sulfat (CAS 64-31-3) Sales by Country (2015-2020) (K MT)
Table 59. Latin America Morphine Sulfat (CAS 64-31-3) Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Morphine Sulfat (CAS 64-31-3) Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Country (2015-2020)
Table 62. Latin America Morphine Sulfat (CAS 64-31-3) Sales by Type (2015-2020) (K MT)
Table 63. Latin America Morphine Sulfat (CAS 64-31-3) Sales Market Share by Type (2015-2020)
Table 64. Latin America Morphine Sulfat (CAS 64-31-3) Sales by Application (2015-2020) (K MT)
Table 65. Latin America Morphine Sulfat (CAS 64-31-3) Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Sales Market Share by Application (2015-2020)
Table 74. Mallinckrodt Pharmaceuticals Corporation Information
Table 75. Mallinckrodt Pharmaceuticals Description and Major Businesses
Table 76. Mallinckrodt Pharmaceuticals Morphine Sulfat (CAS 64-31-3) Production (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Mallinckrodt Pharmaceuticals Product
Table 78. Mallinckrodt Pharmaceuticals Recent Development
Table 79. Alcaliber Corporation Information
Table 80. Alcaliber Description and Major Businesses
Table 81. Alcaliber Morphine Sulfat (CAS 64-31-3) Production (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Alcaliber Product
Table 83. Alcaliber Recent Development
Table 84. Purdue Pharma Corporation Information
Table 85. Purdue Pharma Description and Major Businesses
Table 86. Purdue Pharma Morphine Sulfat (CAS 64-31-3) Production (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Purdue Pharma Product
Table 88. Purdue Pharma Recent Development
Table 89. Cepia-Sanofi Corporation Information
Table 90. Cepia-Sanofi Description and Major Businesses
Table 91. Cepia-Sanofi Morphine Sulfat (CAS 64-31-3) Production (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Cepia-Sanofi Product
Table 93. Cepia-Sanofi Recent Development
Table 94. Macfarlan Smith Corporation Information
Table 95. Macfarlan Smith Description and Major Businesses
Table 96. Macfarlan Smith Morphine Sulfat (CAS 64-31-3) Production (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Macfarlan Smith Product
Table 98. Macfarlan Smith Recent Development
Table 99. SUN PHARMA Corporation Information
Table 100. SUN PHARMA Description and Major Businesses
Table 101. SUN PHARMA Morphine Sulfat (CAS 64-31-3) Production (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. SUN PHARMA Product
Table 103. SUN PHARMA Recent Development
Table 104. Qinghai Pharmaceutical Corporation Information
Table 105. Qinghai Pharmaceutical Description and Major Businesses
Table 106. Qinghai Pharmaceutical Morphine Sulfat (CAS 64-31-3) Production (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Qinghai Pharmaceutical Product
Table 108. Qinghai Pharmaceutical Recent Development
Table 109. Taj Pharmaceuticals Corporation Information
Table 110. Taj Pharmaceuticals Description and Major Businesses
Table 111. Taj Pharmaceuticals Morphine Sulfat (CAS 64-31-3) Production (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Taj Pharmaceuticals Product
Table 113. Taj Pharmaceuticals Recent Development
Table 114. Northeast Pharm Corporation Information
Table 115. Northeast Pharm Description and Major Businesses
Table 116. Northeast Pharm Morphine Sulfat (CAS 64-31-3) Production (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Northeast Pharm Product
Table 118. Northeast Pharm Recent Development
Table 119. Global Morphine Sulfat (CAS 64-31-3) Sales Forecast by Regions (2021-2026) (K MT)
Table 120. Global Morphine Sulfat (CAS 64-31-3) Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global Morphine Sulfat (CAS 64-31-3) Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global Morphine Sulfat (CAS 64-31-3) Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: Morphine Sulfat (CAS 64-31-3) Sales Forecast by Country (2021-2026) (K MT)
Table 124. North America: Morphine Sulfat (CAS 64-31-3) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: Morphine Sulfat (CAS 64-31-3) Sales Forecast by Country (2021-2026) (K MT)
Table 126. Europe: Morphine Sulfat (CAS 64-31-3) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: Morphine Sulfat (CAS 64-31-3) Sales Forecast by Region (2021-2026) (K MT)
Table 128. Asia Pacific: Morphine Sulfat (CAS 64-31-3) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: Morphine Sulfat (CAS 64-31-3) Sales Forecast by Country (2021-2026) (K MT)
Table 130. Latin America: Morphine Sulfat (CAS 64-31-3) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: Morphine Sulfat (CAS 64-31-3) Sales Forecast by Country (2021-2026) (K MT)
Table 132. Middle East and Africa: Morphine Sulfat (CAS 64-31-3) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Morphine Sulfat (CAS 64-31-3) Players
Table 137. Morphine Sulfat (CAS 64-31-3) Customers List
Table 138. Morphine Sulfat (CAS 64-31-3) Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
Table 1. Morphine Sulfat (CAS 64-31-3) Market Segments
Table 2. Ranking of Global Top Morphine Sulfat (CAS 64-31-3) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Morphine Sulfat (CAS 64-31-3) Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Pills
Table 5. Major Manufacturers of Powder
Table 6. COVID-19 Impact Global Market: (Four Morphine Sulfat (CAS 64-31-3) Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Morphine Sulfat (CAS 64-31-3) Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Morphine Sulfat (CAS 64-31-3) Players to Combat Covid-19 Impact
Table 11. Global Morphine Sulfat (CAS 64-31-3) Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Morphine Sulfat (CAS 64-31-3) Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global Morphine Sulfat (CAS 64-31-3) Sales by Regions 2015-2020 (K MT)
Table 14. Global Morphine Sulfat (CAS 64-31-3) Sales Market Share by Regions (2015-2020)
Table 15. Global Morphine Sulfat (CAS 64-31-3) Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Morphine Sulfat (CAS 64-31-3) Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Morphine Sulfat (CAS 64-31-3) Sales Share by Manufacturers (2015-2020)
Table 18. Global Morphine Sulfat (CAS 64-31-3) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Morphine Sulfat (CAS 64-31-3) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Morphine Sulfat (CAS 64-31-3) as of 2019)
Table 20. Morphine Sulfat (CAS 64-31-3) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Morphine Sulfat (CAS 64-31-3) Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Morphine Sulfat (CAS 64-31-3) Price (2015-2020) (USD/Unit)
Table 23. Morphine Sulfat (CAS 64-31-3) Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Morphine Sulfat (CAS 64-31-3) Product Type
Table 25. Date of International Manufacturers Enter into Morphine Sulfat (CAS 64-31-3) Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Morphine Sulfat (CAS 64-31-3) Sales by Type (2015-2020) (K MT)
Table 28. Global Morphine Sulfat (CAS 64-31-3) Sales Share by Type (2015-2020)
Table 29. Global Morphine Sulfat (CAS 64-31-3) Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Morphine Sulfat (CAS 64-31-3) Revenue Share by Type (2015-2020)
Table 31. Morphine Sulfat (CAS 64-31-3) Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Morphine Sulfat (CAS 64-31-3) Sales by Application (2015-2020) (K MT)
Table 33. Global Morphine Sulfat (CAS 64-31-3) Sales Share by Application (2015-2020)
Table 34. North America Morphine Sulfat (CAS 64-31-3) Sales by Country (2015-2020) (K MT)
Table 35. North America Morphine Sulfat (CAS 64-31-3) Sales Market Share by Country (2015-2020)
Table 36. North America Morphine Sulfat (CAS 64-31-3) Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Country (2015-2020)
Table 38. North America Morphine Sulfat (CAS 64-31-3) Sales by Type (2015-2020) (K MT)
Table 39. North America Morphine Sulfat (CAS 64-31-3) Sales Market Share by Type (2015-2020)
Table 40. North America Morphine Sulfat (CAS 64-31-3) Sales by Application (2015-2020) (K MT)
Table 41. North America Morphine Sulfat (CAS 64-31-3) Sales Market Share by Application (2015-2020)
Table 42. Europe Morphine Sulfat (CAS 64-31-3) Sales by Country (2015-2020) (K MT)
Table 43. Europe Morphine Sulfat (CAS 64-31-3) Sales Market Share by Country (2015-2020)
Table 44. Europe Morphine Sulfat (CAS 64-31-3) Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Country (2015-2020)
Table 46. Europe Morphine Sulfat (CAS 64-31-3) Sales by Type (2015-2020) (K MT)
Table 47. Europe Morphine Sulfat (CAS 64-31-3) Sales Market Share by Type (2015-2020)
Table 48. Europe Morphine Sulfat (CAS 64-31-3) Sales by Application (2015-2020) (K MT)
Table 49. Europe Morphine Sulfat (CAS 64-31-3) Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Morphine Sulfat (CAS 64-31-3) Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific Morphine Sulfat (CAS 64-31-3) Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Morphine Sulfat (CAS 64-31-3) Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Morphine Sulfat (CAS 64-31-3) Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific Morphine Sulfat (CAS 64-31-3) Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Morphine Sulfat (CAS 64-31-3) Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific Morphine Sulfat (CAS 64-31-3) Sales Market Share by Application (2015-2020)
Table 58. Latin America Morphine Sulfat (CAS 64-31-3) Sales by Country (2015-2020) (K MT)
Table 59. Latin America Morphine Sulfat (CAS 64-31-3) Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Morphine Sulfat (CAS 64-31-3) Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Country (2015-2020)
Table 62. Latin America Morphine Sulfat (CAS 64-31-3) Sales by Type (2015-2020) (K MT)
Table 63. Latin America Morphine Sulfat (CAS 64-31-3) Sales Market Share by Type (2015-2020)
Table 64. Latin America Morphine Sulfat (CAS 64-31-3) Sales by Application (2015-2020) (K MT)
Table 65. Latin America Morphine Sulfat (CAS 64-31-3) Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Sales Market Share by Application (2015-2020)
Table 74. Mallinckrodt Pharmaceuticals Corporation Information
Table 75. Mallinckrodt Pharmaceuticals Description and Major Businesses
Table 76. Mallinckrodt Pharmaceuticals Morphine Sulfat (CAS 64-31-3) Production (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Mallinckrodt Pharmaceuticals Product
Table 78. Mallinckrodt Pharmaceuticals Recent Development
Table 79. Alcaliber Corporation Information
Table 80. Alcaliber Description and Major Businesses
Table 81. Alcaliber Morphine Sulfat (CAS 64-31-3) Production (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Alcaliber Product
Table 83. Alcaliber Recent Development
Table 84. Purdue Pharma Corporation Information
Table 85. Purdue Pharma Description and Major Businesses
Table 86. Purdue Pharma Morphine Sulfat (CAS 64-31-3) Production (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Purdue Pharma Product
Table 88. Purdue Pharma Recent Development
Table 89. Cepia-Sanofi Corporation Information
Table 90. Cepia-Sanofi Description and Major Businesses
Table 91. Cepia-Sanofi Morphine Sulfat (CAS 64-31-3) Production (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Cepia-Sanofi Product
Table 93. Cepia-Sanofi Recent Development
Table 94. Macfarlan Smith Corporation Information
Table 95. Macfarlan Smith Description and Major Businesses
Table 96. Macfarlan Smith Morphine Sulfat (CAS 64-31-3) Production (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Macfarlan Smith Product
Table 98. Macfarlan Smith Recent Development
Table 99. SUN PHARMA Corporation Information
Table 100. SUN PHARMA Description and Major Businesses
Table 101. SUN PHARMA Morphine Sulfat (CAS 64-31-3) Production (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. SUN PHARMA Product
Table 103. SUN PHARMA Recent Development
Table 104. Qinghai Pharmaceutical Corporation Information
Table 105. Qinghai Pharmaceutical Description and Major Businesses
Table 106. Qinghai Pharmaceutical Morphine Sulfat (CAS 64-31-3) Production (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Qinghai Pharmaceutical Product
Table 108. Qinghai Pharmaceutical Recent Development
Table 109. Taj Pharmaceuticals Corporation Information
Table 110. Taj Pharmaceuticals Description and Major Businesses
Table 111. Taj Pharmaceuticals Morphine Sulfat (CAS 64-31-3) Production (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Taj Pharmaceuticals Product
Table 113. Taj Pharmaceuticals Recent Development
Table 114. Northeast Pharm Corporation Information
Table 115. Northeast Pharm Description and Major Businesses
Table 116. Northeast Pharm Morphine Sulfat (CAS 64-31-3) Production (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Northeast Pharm Product
Table 118. Northeast Pharm Recent Development
Table 119. Global Morphine Sulfat (CAS 64-31-3) Sales Forecast by Regions (2021-2026) (K MT)
Table 120. Global Morphine Sulfat (CAS 64-31-3) Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global Morphine Sulfat (CAS 64-31-3) Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global Morphine Sulfat (CAS 64-31-3) Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: Morphine Sulfat (CAS 64-31-3) Sales Forecast by Country (2021-2026) (K MT)
Table 124. North America: Morphine Sulfat (CAS 64-31-3) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: Morphine Sulfat (CAS 64-31-3) Sales Forecast by Country (2021-2026) (K MT)
Table 126. Europe: Morphine Sulfat (CAS 64-31-3) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: Morphine Sulfat (CAS 64-31-3) Sales Forecast by Region (2021-2026) (K MT)
Table 128. Asia Pacific: Morphine Sulfat (CAS 64-31-3) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: Morphine Sulfat (CAS 64-31-3) Sales Forecast by Country (2021-2026) (K MT)
Table 130. Latin America: Morphine Sulfat (CAS 64-31-3) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: Morphine Sulfat (CAS 64-31-3) Sales Forecast by Country (2021-2026) (K MT)
Table 132. Middle East and Africa: Morphine Sulfat (CAS 64-31-3) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Morphine Sulfat (CAS 64-31-3) Players
Table 137. Morphine Sulfat (CAS 64-31-3) Customers List
Table 138. Morphine Sulfat (CAS 64-31-3) Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Morphine Sulfat (CAS 64-31-3) Product Picture
Figure 2. Global Morphine Sulfat (CAS 64-31-3) Sales Market Share by Type in 2020 & 2026
Figure 3. Pills Product Picture
Figure 4. Powder Product Picture
Figure 5. Global Morphine Sulfat (CAS 64-31-3) Sales Market Share by Application in 2020 & 2026
Figure 6. Oral Tablets
Figure 7. Injection
Figure 8. Capsule
Figure 9. Others
Figure 10. Morphine Sulfat (CAS 64-31-3) Report Years Considered
Figure 11. Global Morphine Sulfat (CAS 64-31-3) Market Size 2015-2026 (US$ Million)
Figure 12. Global Morphine Sulfat (CAS 64-31-3) Sales 2015-2026 (K MT)
Figure 13. Global Morphine Sulfat (CAS 64-31-3) Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Morphine Sulfat (CAS 64-31-3) Sales Market Share by Region (2015-2020)
Figure 15. Global Morphine Sulfat (CAS 64-31-3) Sales Market Share by Region in 2019
Figure 16. Global Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Region (2015-2020)
Figure 17. Global Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Region in 2019
Figure 18. Global Morphine Sulfat (CAS 64-31-3) Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Morphine Sulfat (CAS 64-31-3) Revenue in 2019
Figure 20. Morphine Sulfat (CAS 64-31-3) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Morphine Sulfat (CAS 64-31-3) Sales Market Share by Type (2015-2020)
Figure 22. Global Morphine Sulfat (CAS 64-31-3) Sales Market Share by Type in 2019
Figure 23. Global Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Type (2015-2020)
Figure 24. Global Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Type in 2019
Figure 25. Global Morphine Sulfat (CAS 64-31-3) Market Share by Price Range (2015-2020)
Figure 26. Global Morphine Sulfat (CAS 64-31-3) Sales Market Share by Application (2015-2020)
Figure 27. Global Morphine Sulfat (CAS 64-31-3) Sales Market Share by Application in 2019
Figure 28. Global Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Application (2015-2020)
Figure 29. Global Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Application in 2019
Figure 30. North America Morphine Sulfat (CAS 64-31-3) Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Morphine Sulfat (CAS 64-31-3) Sales Market Share by Country in 2019
Figure 33. North America Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Country in 2019
Figure 34. U.S. Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Morphine Sulfat (CAS 64-31-3) Market Share by Type in 2019
Figure 39. North America Morphine Sulfat (CAS 64-31-3) Market Share by Application in 2019
Figure 40. Europe Morphine Sulfat (CAS 64-31-3) Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Morphine Sulfat (CAS 64-31-3) Sales Market Share by Country in 2019
Figure 43. Europe Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Country in 2019
Figure 44. Germany Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Morphine Sulfat (CAS 64-31-3) Market Share by Type in 2019
Figure 55. Europe Morphine Sulfat (CAS 64-31-3) Market Share by Application in 2019
Figure 56. Asia Pacific Morphine Sulfat (CAS 64-31-3) Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Morphine Sulfat (CAS 64-31-3) Sales Market Share by Region in 2019
Figure 59. Asia Pacific Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Region in 2019
Figure 60. China Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Morphine Sulfat (CAS 64-31-3) Market Share by Type in 2019
Figure 83. Asia Pacific Morphine Sulfat (CAS 64-31-3) Market Share by Application in 2019
Figure 84. Latin America Morphine Sulfat (CAS 64-31-3) Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Morphine Sulfat (CAS 64-31-3) Sales Market Share by Country in 2019
Figure 87. Latin America Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Country in 2019
Figure 88. Mexico Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Morphine Sulfat (CAS 64-31-3) Market Share by Type in 2019
Figure 95. Latin America Morphine Sulfat (CAS 64-31-3) Market Share by Application in 2019
Figure 96. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Country in 2019
Figure 100. Turkey Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Market Share by Type in 2019
Figure 107. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Market Share by Application in 2019
Figure 108. Mallinckrodt Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Alcaliber Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Purdue Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Cepia-Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Macfarlan Smith Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. SUN PHARMA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Qinghai Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Taj Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Northeast Pharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. North America Morphine Sulfat (CAS 64-31-3) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. North America Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Europe Morphine Sulfat (CAS 64-31-3) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. Europe Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Asia Pacific Morphine Sulfat (CAS 64-31-3) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. Asia Pacific Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Latin America Morphine Sulfat (CAS 64-31-3) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 124. Latin America Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 126. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Porter's Five Forces Analysis
Figure 128. Channels of Distribution
Figure 129. Distributors Profiles
Figure 130. Bottom-up and Top-down Approaches for This Report
Figure 131. Data Triangulation
Figure 132. Key Executives Interviewed
Figure 1. Morphine Sulfat (CAS 64-31-3) Product Picture
Figure 2. Global Morphine Sulfat (CAS 64-31-3) Sales Market Share by Type in 2020 & 2026
Figure 3. Pills Product Picture
Figure 4. Powder Product Picture
Figure 5. Global Morphine Sulfat (CAS 64-31-3) Sales Market Share by Application in 2020 & 2026
Figure 6. Oral Tablets
Figure 7. Injection
Figure 8. Capsule
Figure 9. Others
Figure 10. Morphine Sulfat (CAS 64-31-3) Report Years Considered
Figure 11. Global Morphine Sulfat (CAS 64-31-3) Market Size 2015-2026 (US$ Million)
Figure 12. Global Morphine Sulfat (CAS 64-31-3) Sales 2015-2026 (K MT)
Figure 13. Global Morphine Sulfat (CAS 64-31-3) Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Morphine Sulfat (CAS 64-31-3) Sales Market Share by Region (2015-2020)
Figure 15. Global Morphine Sulfat (CAS 64-31-3) Sales Market Share by Region in 2019
Figure 16. Global Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Region (2015-2020)
Figure 17. Global Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Region in 2019
Figure 18. Global Morphine Sulfat (CAS 64-31-3) Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Morphine Sulfat (CAS 64-31-3) Revenue in 2019
Figure 20. Morphine Sulfat (CAS 64-31-3) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Morphine Sulfat (CAS 64-31-3) Sales Market Share by Type (2015-2020)
Figure 22. Global Morphine Sulfat (CAS 64-31-3) Sales Market Share by Type in 2019
Figure 23. Global Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Type (2015-2020)
Figure 24. Global Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Type in 2019
Figure 25. Global Morphine Sulfat (CAS 64-31-3) Market Share by Price Range (2015-2020)
Figure 26. Global Morphine Sulfat (CAS 64-31-3) Sales Market Share by Application (2015-2020)
Figure 27. Global Morphine Sulfat (CAS 64-31-3) Sales Market Share by Application in 2019
Figure 28. Global Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Application (2015-2020)
Figure 29. Global Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Application in 2019
Figure 30. North America Morphine Sulfat (CAS 64-31-3) Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Morphine Sulfat (CAS 64-31-3) Sales Market Share by Country in 2019
Figure 33. North America Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Country in 2019
Figure 34. U.S. Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Morphine Sulfat (CAS 64-31-3) Market Share by Type in 2019
Figure 39. North America Morphine Sulfat (CAS 64-31-3) Market Share by Application in 2019
Figure 40. Europe Morphine Sulfat (CAS 64-31-3) Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Morphine Sulfat (CAS 64-31-3) Sales Market Share by Country in 2019
Figure 43. Europe Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Country in 2019
Figure 44. Germany Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Morphine Sulfat (CAS 64-31-3) Market Share by Type in 2019
Figure 55. Europe Morphine Sulfat (CAS 64-31-3) Market Share by Application in 2019
Figure 56. Asia Pacific Morphine Sulfat (CAS 64-31-3) Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Morphine Sulfat (CAS 64-31-3) Sales Market Share by Region in 2019
Figure 59. Asia Pacific Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Region in 2019
Figure 60. China Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Morphine Sulfat (CAS 64-31-3) Market Share by Type in 2019
Figure 83. Asia Pacific Morphine Sulfat (CAS 64-31-3) Market Share by Application in 2019
Figure 84. Latin America Morphine Sulfat (CAS 64-31-3) Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Morphine Sulfat (CAS 64-31-3) Sales Market Share by Country in 2019
Figure 87. Latin America Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Country in 2019
Figure 88. Mexico Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Morphine Sulfat (CAS 64-31-3) Market Share by Type in 2019
Figure 95. Latin America Morphine Sulfat (CAS 64-31-3) Market Share by Application in 2019
Figure 96. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Revenue Market Share by Country in 2019
Figure 100. Turkey Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Morphine Sulfat (CAS 64-31-3) Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Market Share by Type in 2019
Figure 107. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Market Share by Application in 2019
Figure 108. Mallinckrodt Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Alcaliber Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Purdue Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Cepia-Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Macfarlan Smith Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. SUN PHARMA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Qinghai Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Taj Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Northeast Pharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. North America Morphine Sulfat (CAS 64-31-3) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. North America Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Europe Morphine Sulfat (CAS 64-31-3) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. Europe Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Asia Pacific Morphine Sulfat (CAS 64-31-3) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. Asia Pacific Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Latin America Morphine Sulfat (CAS 64-31-3) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 124. Latin America Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 126. Middle East and Africa Morphine Sulfat (CAS 64-31-3) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Porter's Five Forces Analysis
Figure 128. Channels of Distribution
Figure 129. Distributors Profiles
Figure 130. Bottom-up and Top-down Approaches for This Report
Figure 131. Data Triangulation
Figure 132. Key Executives Interviewed
